Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM- and CoALL-protocols: Results of the German Cooperative Study

Blood

Volumn 78, Issue 10, 1991, Pages 2780-2784

  Dopfer, R ^a   Henze, G ^a   Bender Gotze, C ^a   Ebell, W ^a   Ehninger, G ^a   Friedrich, W ^a   Gadner, H ^a   Klingebiel, T ^a   Peters, C ^a   Riehm, H ^a   Suttorp, M ^a   Schmid, H ^a   Schmitz, N ^a   Siegert, W ^a   Stollmann Gibbels, B ^a   Hartmann, R ^a   Niethammer, D ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; METHOTREXATE; PREDNISOLONE; THYMOCYTE ANTIBODY;

ACUTE LYMPHOBLASTIC LEUKEMIA; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CHILD; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECURRENT DISEASE; THERAPY;

EID: 0025789913     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v78.10.2780.bloodjournal78102780     Document Type: Article

References (0)